Lessons from organoid engineering for rheumatic disease

Janus kinase inhibitors alter NK cell phenotypes and inhibit their antitumour capacity

Antisynthetase syndrome and cardiac involvement: a rare association

Reply to the comment of Sartorelli et al. "Diagnostic approach and novel therapeutic option for cardiac inflammatory disorders"

Update on the Aetiopathogenesis of Sjögren Disease: From Interferon Signaling to Epithelial Dysfunction

Development of salivary gland organoids derived from patient biopsies: a functional model of Sjögren's disease

Characterisation of airway disease associated with Sjögren disease

JAK inhibitor withdrawal causes a transient pro-inflammatory cascade: A potential mechanism for major adverse cardiac events

JAK Inhibitor Withdrawal Causes a Transient Proinflammatory Cascade: A Potential Mechanism for Major Adverse Cardiac Events

Whipple disease mimicking polymyalgia rheumatica with initial response to tocilizumab